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There has been controversy concerning the nature of the 
bullous pemphigoid (BP) antigen: immunoprecipitation 
identified BP antigen as a single, unique 230-kOa protein, 
whereas immunoblot analysis showed multiple antigen mole-
cules, mainly 230- and 170-kOa proteins. In this study, to 
further characterize the 170-kOa protein, we have examined 
whether the 170-kOa protein is detected by immunoprecipi-
tation. Extracts of human squamous cell carcinoma cells re-
vealed the 170-kOa protein with immunoblot analysis. Al-
though the conventional immunoprecipitation detected only 
the 230-kOa protein, some BP sera that detected the 170-
Bullous pemphigoid (BP) is an autoimmune skin disease characterized by tense blisters due to cleft formation at the basement membrane zone (BMZ) [1]. In most cases, circulating autoantibodies against the epidermal basement membrane zone (BMZ) are detected [2] . 
These autoantibodies are considered to play an important role in the 
pathogenesis of BP [3 -6]. There is uncertainty about the BP anti-
gens that are defined immunologically by anti-BMZ antibodies. 
Some studies have suggested that BP antibodies recognize a single 
antigen [7 -10], whereas other studies have indicated the molecular 
heterogeneity in BP antigens [11-13]. In general, BP antigen was 
identified as a uni<J.ue 230-kDa protein by means ofimmunoprecipi-
tation technique l7 -10]; however, immunoblot analysis showed 
several different BP antigens, including 230- and 170-kDa proteins 
[12-13]. 
To clarify this discrepancy, we examined whether the 170-kDa 
protein is detected by immunoprecipitation technique. Immuno-
blot analysis of human squamous cell carcinoma cells detected 
both the 230- and 170-kDa proteins. Immunofluorescence study 
suggested that the two proteins are located in hemidesmosomes. 
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Abbreviations: 
BMZ: basement membrane zone 
BP: bullous pemphigoid 
EDT A: ethylenediaminetetraacetic acid 
Ig: immunoglobulin(s) 
IlF: indirect immunofluorescence 
MoAb: monoclonal antibody 
P AGE: polyacrylamide gel electrophoresis 
PBS: phosphate-buffered saline, pH 7.4 
PMSF: phenylmethylsulfonyl fluoride 
SDS: sodium dodecyl sulfate 
TBS: Tris-HCI- buffered saline, pH 8.0 
kOa protein with immunoblotting also precipitated the 170-
kOa protein with our modified immunoprecipitation, in 
which the cells were extracted with 1 % sodium dodecylsul-
fate (SOS) buffer and reacted with the sera under reduced 
SOS concentration. The 170-kOa protein-specific BP sera 
clearly showed hemidesmosomal plaque staining with immu-
nofluorescence of cultured cells. These results indicate that 
the 170-kOa protein is indeed one of the BP antigens and that 
the 230- and 170-kOa BP antigens are integrated in different 
ways in hemidesmosomes.] Invest DermatoI100:176-179, 
1993 
Furthermore, the 170-kDa protein was clearly demonstrated by our 
modified immunoprecipitation using 1 % sodium dodecyl sulfate 
(SDS) for cell extraction. These results suggest that the two BP 
antigens are present in different ways in hemidesmosomes. 
MATERIALS AND METHODS 
Sera Nine sera were obtained from clinically, histologically, and 
immunohistologically typical patients with BP (BP1-BP9). Six 
sera from healthy volunteers were used as normal controls. All sera 
were stored at-20 °C and at 4°C in the presence of 0.1 % NaN) for 
less than 1 month during these experiments. 
Monoclonal Antibody (MoAb) A mouse MoAb, D-20, was a 
generous gift from Dr. K. Owaribe. The MoAb was produced 
by standard hybridoma technique using the SDS-polyacrylarnide 
gel electrophoresis (PAGE)-eluted 170-kDa protein of hemides-
mosomal preparation obtained from bovine corneal epithelium 
[14,15]. 
Cell Line KU8 cell used in this study was a human squamous 
cell carcinoma cell line derived from a penile carcinoma. Char-
acteristics and culture condition of KU8 cells were previously de-
scribed [16]. 
Immunoblot Analysis Immunoblot assay using ethylenedia-
minetetraacetic acid (EDT A) - separated normal human ef.idermal 
extracts was performed as described previously [12,13, except 
that peroxidase - conjugated anti-mouse immunoglobulins (Igs) 
(DAKO, Copenhagen, Denmark) was used as a second antibody for 
MoAb D-20. To detect the expression of BP antigens in KU8 cells 
by immunoblotting, we used a modification of the method for nor-
mal human epidermis. Briefly, confluent cultures ofKU8 cells were 
scraped in 0.01 M Tris-HCI buffer, pH 6.8, containing 1% SDS, 
5% p-mercaptoethanol, 2 mM EDTA, 2 mM phenylmethylsul-
fonyl fluoride (PMSF), and 5 mg/liter each oHour proteinase inhibi-
tors (Ieupeptin, antipain, chymostatin, and pepstatin A; Sigma 
Chemical Co., St. Louis, MO), boiled for 5 min, centrifuged at 
10,000 X g for 40 min, and supernatant was harvested as an antigen 
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Figure 1. Immunoblot analysis. (A - C) The positions of the 230- and 170-kOa proteins are indicated on the lift; bars on the right indicate the positions of 
standard molecular weight markers, from top to bottom: 200-, 116-, and 97-kOa. (A) Normal human epidermal extracts. (B) Normal epidermal extracts for 
MoAb 0-20. The MoAb showed a little weak but clear reactivity with the 170-kOa protein. (C) KUB cell extracts. BP3-BP6 specifically labeled doublet 
bands of approximately 170-kOa . (CONT) control. 
source. SDS-PAGE and immunostaining of the blots were per-
formed by the same method described previously [1 3]. 
Indirect Immunofluorescence (llF) To detect BP antigen ex-
pression in cultured cells by IIF, KU8 cells were cultured on glass 
covers lips to near confluence, fixed with acetone at -20°C for 
20 min, and extracted with 0.5% Triton X-I00 in phosphate-buf-
fered saline (PBS), pH 7.4, for 15 min at room temperature. The 
coverslips were first blocked with PBS containing 1 % bovine serum 
albumin and 0.1 % NaN3 for 30 min at room temperature and then 
incubated with sera or MoAb appropriately diluted in the same 
buffer for 1 h at room temperature. After washing for 15 min with 
PBS, the coverslips were incubated with 1: 800 diluted fluorescein 
isothiocyanate-conjugated anti-human IgG rabbit antiserum or 
anti-mouse Igs rabbit antiserum (DAKO) for human sera or MoAb 
D-20, respectively , as second antibodies. After extensive washing 
w ith PBS, the covers lips were examined by fluorescence micro-
scopy (Optiphot EFD2, Nikon, Tokyo, Japan). 
In some experiments, the extraction step with 0.5% Triton 
X -IOO was omitted to determine the possibility that this procedure 
may remove some pool of BP antigen present in the cytoplasm. 
IrnUlUnoprecipitation Analysis Immunoprecipitation was per-
formed mainly according to the method described by Stanley 
et al [7]. Briefly, KU8 cells were radiolabeled with 35S-methionine 
(0.925 X 106 Bqjml) in methionine-free medium containing 10% 
fe tal calf serum and lysed with 0.5% Nonidet P-40 in the Tris-Hcl -
buffered saline (TBS), pH 8.0, containing 2 mM PMSF. After cen-
trifugation at 10,000 Xg at 4°C for 40 min, the supernatant was 
dialyzed against 0.3% Nonidet P-40 and 2 mM PMSF in TBS over-
night and stored at - 80°C as aliquots. To reduce nonspecific back-
ground, the 200-lll antigen sample was first preabsorbed with 20 III 
of combined sera from three normal volunteers at 4 ° C overnight 
and precipitated with 60 III protein G sepharose slurry (Pharmacia, 
Uppsala, Sweden) at 4°C for 30 min. Fifteen microliters of preab-
sorbed antigen sample was incubated with 3 III BP or normal sera or 
20 ,ull : 20 diluted MoAb D-20 ascites at 4 °C overnight. Antigen-
antibody complexes were precipitated by incubation with 3 ,ul pro-
tein G sepharose slurry at 4°C fo~ 30 min. After the precipitates 
were washed six times with TBS containing 0.3% Nonidet P-40, 
0.3% sodium deoxycholate, and 2 mM PMSF, protein G, Igs, and 
antigens were dissociated by boiling in Laemmli's sample buffer 
under the reducing condition (0.00625 M Tris-HCl, pH 6.8, con-
taining 2% SDS and 5% p-mercaptoethanol), and protein G was 
removed by centrifugation. After proteins were fractionated by 
SDS-PAGE, gels were dried and processed for fluorography . 
To release proteins more extensively, we modified the extraction 
procedure according to the immunoprecipitation for desmocollins I 
and II described by Parrish et at [17] . Briefly, the cells were extracted 
with the same extraction buffer as that used for immunoblot analysis 
(i.e., Tris-HCI ~uffer suppleme~ted ~ith. 1.% SDS, 5% p-mercap-
toethanol, and SIX different protemase mhlbltors). After centrifuga-
tion at 10,000 X g at 4°C for 40 min, the supernatant was dialyzed 
at 4 °C overnight against TBS containing 0.1 % SDS and 2 mM 
PMSF to reduce the SDS concentration in the sample solution. 
Procedures fo llowing this were the same as those for the conven-
tional immunoprecipitation. 
RESULTS 
Immunoblot Analysis Immunoblotting of the normal human 
epidermal extracts with the sera from BP patients BP1 and BP2 
detected both the 230- and 170-kDa proteins, whereas the sera from 
patients BP3 - BP6 reacted only with the 170-kDa protein, and the 
sera from patients BP7 - BP9 reacted only with the 230-kDa pro-
tein. However, the SIX control s~ra reacted with neither protein (Fig 
lA). MoAb D-20 detected a sll1gle 170-kDa protein band in the 
human epidermal extracts that showed the same mobility as the 
170-kDa protem recogl1lzed by some BP sera (Fig IB). Immuno-
blotting of the extracts of KU8 cells with the BP sera showed these 
two proteins in the same pattern, although the 170-kDa protein 
appeared to be doublet bands (Fig 1 C). This confirmed that both 
230- and 170-kDa proteins are also expressed in KU8 cells. 
IIF When KU8 cells were fixed with acetone and treated with 
0.5% !riton X-~OO , all BP sera displayed numerous punctate arrays 
in various densities and patterns at the lower cell surface (Fig 2A,B). 
These staining patterns are characteristic of the hemidesmosomal 
plaque seen in cultured epithelial cells [15,18,19]; however, no 
apparent difference of reactivity was seen·between the BP sera reac-
ting only with the 230-kDa protein on immunoblotting (Fig 2A) 
and the BP sera reacting only with the 170-kDa protein 
(Fig 2B). MoAb D-20 also exhibited the same pattern of reactivity 
(Fig 2D); however, none of the six control sera showed this positive 
staining (Fig 2C). 
When the 0.5% Triton X-lOO extraction step was omitted, all BP 
sera sti ll showed specific hemidesmosomal plaque staining, al-
though coarse, granu lar, nonspecific fluorescence increased slightly 
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Figure 2. Immunofluorescence using acetone fixed- and Triton X-IOO 
treated-KUB cells. (A) BP3 serum. (B) BP7 serum. (C) Normal control 
serum did not show this specific staining. (D) MoAb 0-20 also showed 
the similar reactivity. Bar, 20 11m. 
(data not shown); however, no apparent difference of reactivity was 
seen between the 230-kDa protein- specific BP sera and the 170-
kDa protein - specific BP sera. 
hnrnunoprecipitation The conventional immunoprecipitation 
revealed that all the BP sera reactive with the 230-kDa protein by 
immunoblotting precipitated the 230-kDa protein from the cell 
extract with 0.5% Nonidet P-40 buffer, although the 170-kDa 
protein was not precipitated by any sera (Fig 3A). 
When cell extracts were prepared in the presence of 1 % SDS and 
dialyzed against 0.1 % SDS buffer, the 230-kDa protein was de-
tected by all of the BP sera reactive with the 230-kDa protein by 
immunoblotting, although the 170-kDa antigen was not detected 
(data not shown) . This concentration ofSDS does not interfere with 
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the binding of desmoglein I or desmocollins I and II to their specific 
MoAb [17] and does not interfere with the binding of the 230-kDa 
antigen to the autoantibody. To avoid the possibility that the bind-
ing of the 170-kDa protein to its antibody is prevented by this SDS 
concentration, we further diluted the dialyzed SDS extract 10 times 
with TBS and subsequently incubated it with BP sera. All of the BP 
sera reactive with the 170-kDa protein by immunoblotting precipi-
tated the 170-kDa antigen from this antigen sample (Fig 3B). Nei-
ther the two BP sera reactive with only the 230-kDa protein nor the 
three control sera that were not used for pre-clearance of the cell 
extract precipitated the 170-kDa protein. Although the signal was 
weak from the same antigen sample, MoAb D-20 also precipitated 
the 170-kDa protein, which showed the same mobility as that pre-
cipitated by BP sera (Fig 3C). 
DISCUSSION 
In the present study, we showed for the first time that the 170-kDa 
protein can be detected by immunoprecipitation. We first con-
firmed that the BP sera detect both the 230- and 170-kDa proteins 
with immunoblot analysis by using extracts of cultured human 
squamous cell carcinoma cells (KU8 cells) in a pattern similar to that 
produced by normal human epidermal extract. That both the 230-
and 170-kDa proteins are expressed in KU8 cells was confirmed by 
the result of IIF, in which characteristic hemidesmosomal plaque 
staining was clearly detected by both the 230- and the 170-kDa 
protein - specific BP sera. The pattern of reactivity was indistin-
guishable from that by MoAb D-20. 
Like previous reports [7 - 10], with conventional immunoprecipi-
tation, only the 230-kDa protein was detected from Nonidet P-40 
extracts; however, if the radiolabeled cells were extracted with 1% 
SDS, and antigen-antibody complex was produced in the presence 
of a reduced SDS concentration, both the 230- and 170-kDa pro-
teins were detected. The pattern of reactivity with the two proteins 
was the same as that with immunoblot analysis . That MoAb D-20 
also precipitated the 170-kDa protein in SDS extracts further con-
firmed the specificity of this reactivity. These results indicate that 
the 170-kDa protein may be extracted in the presence of 1 % SDS 
but not by 0.5% Nonidet P-40 buffer because the 170-kDa protein 
is integrated in hemidesmosomes more strongly than the 230-kDa 
protein. A less likely possibility is that the 170-kDa protein is ex-
tremely sensitive to proteases. In our modified immunoprecipita-
tion using 1 % SDS for cell extraction, SDS may inactivate proteases 
by denaturation, and therefore the 170-kDa protein can be detected. 
Another possibility is that non-ionic detergents, such as Nonidet 
P-40, conceal the epitopes of the 170-kDa protein. 
Mueller et al [11] reported that a very faint 166-kDa protein band 
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Figure 3. lmmunoprecipitation. (A) Conventional nonidet P-40 extracts; ., the position of nonspecific band of approximately 200 kOa, which is 
constantly observed in this irnrnunoprecipitation, even by control (CONT) serum. (B) SOS extracts. (C) SOS extracts for MoAb 0-20. (See Fig I for 
explanation of the arrows and IJars.) 
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was occasionally detected with the conventional immunoprecipita-
tion. This 166-kDa protein may be the same as the 170-kDa pro-
tein; however, because this protein was always associated with the 
more prominent 230-kDa protein, they considered that the 166-
kDa protein may be a degradation product of the 230-kDa protein. 
Contrary to this report, our immunoprecipitation using 1 % SDS 
buffer for extraction clearly detected a 170-kDa protein that was not 
necessarily associated with the 230-kDa protein. Moreover, the 
pattern of reactivity on immunoprecipitation was the same as that 
on immunoblotting for each serum. These results suggest that the 
170-kDa protein is not a degradation product of the 230-kDa pro-
tein but is an intrinsic molecule. 
Although the 230-kDa protein was immunoprecipitated from 
the 1 % SDS extract of KU8 cells after dialysis against 0.1 % SDS-
TBS, the 170-kDa antigen was not immunoprecipitated from the 
same sample but could be detected after the sample was tenfold 
further diluted. The 230-kDa protein may be bound by its corre-
sponding antibody under the condition containing 0.1 % SDS, 
whereas the 170-kDa protein is capable of making complexes with 
its antibody at an SDS concentration of less than 0.1 %. This differ-
ence of affinity for the antibodies may also suggest the different 
characteristics between the 230- and 170-kDa proteins. 
Because the BP sera reactive only with the 170-kDa antigen 
stained the hemidesmosomal plaque ofKU8 cells in the same man-
ner as the 230-kDa antigen-specific BP sera and MoAb D-20, the 
170-kDa BP antigen is most likely located in the hemidesmosome. 
Recently, cDNA encoding the 170-kDa BP antigen has been 
cloned, although the cDNA does not cover the complete molecule 
[20]. The 230-kDa BP antigen has been extensively investigated 
using its cDNA [21-23]; however, the real nature of the 170-kDa 
BP antigen has not been revealed . So far, only four molecules have 
been identified as hemidesmosomal components, namely, the 230-
and 170-kDa BP antigens [20-23], the a6fJ4-integrin complex 
[24,25], and epiligrin [26]. In the future, studies of these proteins, 
including isolation and characterization of cDNA encoding entire 
molecules of the 170-kDa BP antigen, will unravel the structure 
and function of hemidesmosomes, the most important apparatus of 
cell- substrate adhesion of epidermis. 
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